Teladoc Health: Buy After COVID-19 Bubble Ends
- Teladoc Health trades back to pre-covid levels despite forecasted strong growth.
- The telehealth provider continues to expand health products pushing strong into mental health with a higher recurring visit stream.
- The stock trades at only 33x '22 EBITDA targets, nearly equal to revenue growth targets.
- Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio. Learn More »